Delivery Order SPE2DB22D9225-SPE2DB23FR8EP
Award Date 7/21/23
Potential Completion Date 7/24/23
Potential Value $26K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $34,490.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the supply of 120 capsules of XTANDI 40 MG CAPSULE. The place of performance will be Park Ridge, Illinois and the period of performance is from August 11, 2023 through August 14, 2023. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency (DLA), a combat support agency within the Department of Defense (DoD), awarded a $12,934.05 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 120 capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois from August 18-21, 2023. DLA manages the global supply chain for the DoD and this order is likely to fulfill pharmaceutical needs for a treatment regimen at one or more military medical treatment facilities in the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at forty-three thousand one hundred thirteen dollars and fifty cents ($43,113.50) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG per capsule. The place of performance will be Park Ridge, Illinois for the period of August 28, 2023 through August 29, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports military readiness by...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand, eight hundred sixty-eight dollars and ten cents ($25,868.10) to DMS Pharmaceutical Group Inc. for the procurement of one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE to be delivered to a location in Park Ridge, Illinois. The order was placed under an unspecified contracting vehicle and has a period of performance spanning September 18, 2023 through September 19, 2023. No set-aside...
- The Defense Logistics Agency awarded a $25,868.10 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to Park Ridge, Illinois. The order was placed under an unspecified contract vehicle to supply pharmaceutical products and services in support of Department of Defense health programs. Performance is required from August 2nd through August 3rd, 2023. No subcontractors or set aside designations were identified. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at seventy-seven thousand six hundred four dollars and thirty cents ($77,604.30) to DMS Pharmaceutical Group Inc. as the prime contractor. The firm fixed price order is for the delivery of one hundred twenty (120) capsules of XTANDI 40 MG to an address in Park Ridge, Illinois. The order was issued on August 24, 2023 with performance required by August 25, 2023. No set aside designation or subcontracting details were provided. The...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand, eight hundred sixty-eight dollars and ten cents ($25,868.10) to DMS Pharmaceutical Group Inc. for the procurement of one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE to be delivered to Park Ridge, Illinois. The order was placed under an unspecified contract vehicle and has a period of performance from September 5, 2023 through September 6, 2023. No set aside designations or...
- The Defense Logistics Agency (DOD) awarded a $8,622.70 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the provision of 4561152075 XTANDI 40 MG CAPSULE 120S. The place of performance is Park Ridge, Illinois. The period of performance is one day, from June 6, 2023 through June 7, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the United States military and supports procurement and distribution...
- The Defense Logistics Agency (DOD) awarded a $8,622.70 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to Park Ridge, Illinois. The delivery order was issued under an unspecified government-wide acquisition contract vehicle and has a period of performance from August 11-14, 2023. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing medical supplies to...
- The Defense Logistics Agency (DOD) awarded a $12,934.05 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to Park Ridge, Illinois. As a prime contractor supporting DOD procurement needs, DMS Pharmaceutical will provide the specified pharmaceutical products to the customer between September 28-29, 2023 in fulfillment of this delivery order issued against an existing DOD-wide supply contract vehicle. No subcontractors or set...
- SPE2DB22D9225Indefinite Delivery Contract
- SPE2DB22D9225-SPE2DB23FR8EPDelivery Order
The Defense Logistics Agency (DOD) awarded a $25,868.10 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of 120 capsules of XTANDI 40 MG CAPSULE. The place of performance is Park Ridge, Illinois. The period of performance is from July 21, 2023 through July 24, 2023. No set aside designation or subcontractors are indicated. The DLA procures and provides logistics support for medical supplies and pharmaceuticals in support of military treatment facilities and healthcare programs within the Department of Defense.
Generated 12/20/23, 12:20 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 7/21/23 |